Bruce Car - 02 Nov 2023 Form 4 Insider Report for Biohaven Ltd. (BHVN)

Role
Chief Scientific Officer
Signature
/s/ George Clark, Attorney-in-Fact
Issuer symbol
BHVN
Transactions as of
02 Nov 2023
Net transactions value
$0
Form type
4
Filing time
06 Nov 2023, 20:32:10 UTC
Previous filing
05 Oct 2022
Next filing
04 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Stock Options (Right to buy) Award $0 +78,750 $0.000000 78,750 02 Nov 2023 Common Shares 78,750 $29.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in four equal installments on November 2, 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service with the Issuer at each vesting date.